권영직 (University of California, Irvine)님 | 한빛사연구자 > 한빛사

University of California, Irvine

바이오센싱 및 나노바이오물질

최종업데이트 2023.02.08.

Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation
- Nano Converg., 13 April 2026;Volume 13, article number 13, (2026) | https://doi.org/10.1186/s40580-026-00543-3
- 2026-04
- 바이오·의료융합
- 한빛사논문
- 권영직(University of California, Irvine)
Nanocomplexes of doxorubicin and DNA fragments for efficient and safe cancer chemotherapy
- J. Control. Release, Volume 354, Feb 2023, Pages 91-108 | https://doi.org/10.1016/j.jconrel.2022.12.048
- 2023-01
- 바이오·의료융합
- 한빛사논문
COVID-19 vaccines: The status and perspectives in delivery points of view
- Adv. Drug Deliv. Rev., Available online 24 December 2020 | https://doi.org/10.1016/j.addr.2020.12.011
- 2020-12
- 바이오·의료융합
- 한빛사논문
- 권영직(University of California, Irvine)
Synthetically Engineered Adeno-Associated Virus for Efficient, Safe, and Versatile Gene Therapy Applications
- ACS Nano, Publication Date:October 19, 2020 | https://doi.org/10.1021/acsnano.0c03850
- 2020-10
- 바이오·의료융합
- 한빛사논문
- 권영직(University of California, Irvine)
Cancer Cell-Derived, Drug-Loaded Nanovesicles Induced by Sulfhydryl-Blocking for Effective and Safe Cancer Therapy
- ACS Nano, Publication Date (Web): August 21, 2018 | DOI: 10.1021/acsnano.8b05377
- 2018-08
- 바이오·의료융합
- 한빛사논문
Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives
- Prog. Retin. Eye Res., Available online 31 October 2017 | https://doi.org/10.1016/j.preteyeres.2017.10.004
- 2017-10
- 바이오·의료융합
- 한빛사논문, 상위피인용논문
Viral/Nonviral Chimeric Nanoparticles To Synergistically Suppress Leukemia Proliferation via Simultaneous Gene Transduction and Silencing
- ACS Nano, Publication Date (Web): July 29, 2016 | DOI: 10.1021/acsnano.6b04155
- 2016-07
- 바이오·의료융합
- 한빛사논문
- 권영직(University of California, Irvine)
“Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy
- Adv. Drug Deliv. Rev., Available online 4 November 2015 | doi:10.1016/j.addr.2015.10.019
- 2015-11
- 바이오·의료융합
- 한빛사논문, 상위피인용논문
“Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era
- J. Control. Release, Volume 156, Issue 2, 10 December 2011, Pages 128–145 | DOI: 10.1016/j.jconrel.2011.07.002
- 2011-12
- 바이오·의료융합
- 상위피인용논문
- 권영직(University of California, Irvine)
Before and after Endosomal Escape: Roles of Stimuli-Converting siRNA/Polymer Interactions in Determining Gene Silencing Efficiency
- Acc. Chem. Res., 2012, 45 (7), pp 1077–1088 | DOI: 10.1021/ar200241v
- 2012-07
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기